Anti-tumor necrosis factor alpha monoclonal antibody (infliximab) for the treatment of Pyoderma gangrenosum associated with Crohn's disease

被引：0

作者：

Zaccagna, A

Bertone, A

Puiatti, P

Picciotto, F

Sprujevnik, T

Santucci, R

Rossini, FP

机构：

[1] IRCC, Inst Canc Res & Treatment, Operat Unit Dermatol Surg, I-10060 Candiolo, Italy

[2] Hosp S Giovanni AS, Dept Oncol, Unit Gastroenterol Endoscopy, I-10123 Turin, Italy

来源：

EUROPEAN JOURNAL OF DERMATOLOGY | 2003年 / 13卷 / 03期

关键词：

Crohns disease; infliximab; neutrophilic dermatoses; Pyoderma gangrenosum; therapy; tumor-necrosis-factor-alpha;

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Here we report a case of Pyoderma gangrenosum (PG) associated with Crohn's disease successfully treated with infliximab. The efficacy of this drug in many inflammatory diseases has already been reported, but its use in PG has only been seen in very few cases. Our study confirms that this therapy is a valid alternative solution for treating PG, which is often unresponsive to conventional therapies.

引用

页码：258 / 260

页数：3

共 50 条

[21] The Efficacy of Anti-Tumor Necrosis Factor Alpha for Symptomatic Stricturing Small Bowel Crohn's Disease
Alourfi, Mansour
Mosli, Mahmoud
Saadah, Omar, I
CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (09)
[22] Remission of Behcet's disease with anti-tumor necrosis factor monoclonal antibody therapy: a case report
Salvatore Gulli
Carlo Arrigo
Loredana Bocchino
Lucia Morgante
Donatella Sangari
Irene Castagna
Gian Filippo Bagnato
BMC Musculoskeletal Disorders, 4
[23] The Effect of Anti-Tumor Necrosis Factor Alpha Agents on Postoperative Anastomotic Complications in Crohn's Disease: a Systematic Review
El-Hussuna, Alaa
Krag, Aleksander
Olaison, Gunnar
Bendtsen, Flemming
Gluud, Lise L.
DISEASES OF THE COLON & RECTUM, 2013, 56 (12) : 1423 - 1433
[24] Genetic polymorphisms predict response to anti-tumor necrosis factor treatment in Crohn's disease
Netz, Uri
Carter, Jane Victoria
Eichenberger, Maurice Robert
Dryden, Gerald Wayne
Pan, Jianmin
Rai, Shesh Nath
Galandiuk, Susan
WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (27) : 4958 - 4967
[25] Loss of Response to Anti-Tumor Necrosis Factor Alpha Therapy in Crohn's Disease Is Not Associated with Emergence of Novel Inflammatory Pathways
Luther, Jay
Gala, Manish
Patel, Suraj J.
Dave, Maneesh
Borren, Nynke
Xavier, Ramnik J.
Ananthakrishnan, Ashwin N.
DIGESTIVE DISEASES AND SCIENCES, 2018, 63 (03) : 738 - 745
[26] Scrotal pyoderma gangrenosum associated with Crohn's disease
Ho, S. A.
Tan, W. P.
Tan, A. W.
Wong, S. N.
Chua, S. H.
SINGAPORE MEDICAL JOURNAL, 2009, 50 (12) : E397 - E400
[27] Beneficial effect of treatment with a monoclonal anti-tumor necrosis factor-α antibody on markers of coagulation and fibrinolysis in patients with active Crohn's disease
Hommes, DW
van Dullemen, HM
Levi, M
Van der Ende, A
Woody, J
Tytgat, GNJ
van Deventer, SJH
HAEMOSTASIS, 1997, 27 (06) : 269 - 277
[28] Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis
Tilg, H
Jalan, R
Kaser, A
Davies, NA
Offner, FA
Hodges, SJ
Ludwiczek, O
Shawcross, D
Zoller, H
Alisa, A
Mookerjee, RP
Graziadei, N
Datz, C
Trauner, M
Schuppan, D
Obrist, P
Vogel, W
Williams, R
JOURNAL OF HEPATOLOGY, 2003, 38 (04) : 419 - 425
[29] Anti-tumor necrosis factor agents in Crohn's disease and ulcerative colitis: Beyond luminal disease
Nunez-Gomez, Laura
Mesonero-Gismero, Francisco
Albillos-Martinez, Agustin
Lopez-Sanroman, Antonio
GASTROENTEROLOGIA Y HEPATOLOGIA, 2018, 41 (09): : 576 - 582
[30] Pneumocystis carinii pneumonia during maintenance anti-tumor necrosis factor-α therapy with infliximab for Crohn's disease
Velayos, FS
Sandborn, WJ
INFLAMMATORY BOWEL DISEASES, 2004, 10 (05) : 657 - 660

← 1 2 3 4 5 →